Maynard Um
-
-
-
-
-
-
-
Artelo Biosciences files $6.5M at-the-market offering prospectus
-
-
-
-
-
-
-
Artelo Biosciences reports $12.9 million loss for fiscal 2025
-
-
-
-
-
-
-
D. Boral Capital Downgrades Artelo Biosciences, Inc. (ARTL) to Hold
-
-
-
-
-
-
-
Artelo Biosciences (ARTL) Announces Positive First-in-Human Data for ART26.12
-
-
-
-
-
-
-
Artelo Biosciences (ARTL) Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia
-
-
-
-
422,977 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

